Doxil-induced regression of pleuro-pulmonary metastases in a patient with malignant meningioma

Anti-Cancer Drugs

Volumn 14, Issue 3, 2003, Pages 247-250

  Travitzky, Mila ^a   Libson, Eugene ^b   Nemirovsky, Igor ^b   Hadas, Irit ^a   Gabizon, Alberto ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Doxil; Malignant meningioma; Pleuro pulmonary metastases

Indexed keywords

AMIFOSTINE; DOXORUBICIN;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CASE REPORT; DRUG HALF LIFE; DRUG PENETRATION; FEMALE; HAND FOOT SYNDROME; HUMAN; LUNG METASTASIS; MALIGNANT MENINGIOMA; MICROVASCULATURE; NEUTROPENIA; PLEURA METASTASIS; PRIORITY JOURNAL; STOMATITIS;

ANTINEOPLASTIC AGENTS; DOXORUBICIN; FEMALE; HUMANS; LUNG NEOPLASMS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT;

EID: 0037359460     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200303000-00009     Document Type: Article

References (16)

1. LeMay DR, Bucci MN, Farhat SM, Malignant transformation of recurrent meningioma with pulmonary metastases. Surg Neurol 1989; 31:365-368.
2. Baisden BL, Hamper UM, Ali SZ, Metastatic meningioma in fine-needle aspiration (FNA) of the lung: cytomorphologic finding. Diagn Cytopathol 1999; 20:291-294.
3. Figueroa BE, Quint DJ, McKeever PE, Chandler WF. Extracranial metastatic meningioma. Br J Radiol 1999; 72:513-516.
4. Adlakha A, Krishna R, Adlakha H, Perry A, Crotty TB, Scheithauer BW, et al. Meningioma metastatic to the lung. Mayo Clin Proc 1999; 74:1129-1133.
5. Safneck JR, Halliday WC, Quinonez G. Metastatic meningioma detected in pleural fluid. Diagn Cytopathol 1998; 18:453-457.
6. Kodama K, Doi O, Higashiyama M, Horai T, Tateishi R, Nakagawa H. Primary and metastatic pulmonary meningioma. Cancer 1991; 67:1412-1417.
7. Williamson BE, Stanton CA, Levine EA. Chest wall metastasis from recurrent meningioma. Am Surg 2001; 67:966-968.
8. Gabizon AA, Pegylated liposomal Doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest 2001; 19:424-436.
9. Koukourakis MI, Koukouraki S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S, et al. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours. Br J Cancer 2000; 83:1281-1286.
10. Fabel K, Dietrich J, Hau P, Wismeth C, Winner B, Przywara S, et al. Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer 2001; 92; 1936-1942.
11. Siegal T, Horowitz A, Gabizon A. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy. J Neurosurg 1995; 83:1029-1037.
12. Lyass O, Uziely B, Ben-Yosef R, Tzemach D, Heshing NI, Lotem M, et al. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer 2000; 89:1037-1047.
13. Colbern GT, Steinmetz K, Bandak S, Johnson LG, Musterer RS, Hiller AG, et al. Amifostine reduces severity and incidence of Doxil-induced palmar/plantar erythrodysesthesia in rats but does not reduce Doxil antitumor efficacy or alter pharmacokinetics in mice. Proc Am Soc Clin Oncol 2000; 19:abstr 815.
14. Christov C, Lechapt-Zalpman E, Adle-Biassette H, Nachev S, Gherardi RK. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 1999; 98:414-420.
15. Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 2001; 7:243-254.
16. Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994; 54:987-992.